ABCC2 and Thrombocytopenia: ABCC2 rs3740066(C3972T, Ile1324Ile) T allele was suggested as a risk factor for grade 3-4 thrombocytopenia in 445 NSCLC patients receiving platinum-based chemotherapy (OR = 2.43; 95% CI: 1.06–5.56; p = 0.034) (Han et al., 2011).